Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer: cryotherapy.

Katsuto Shinohara1

  • 1Department of Urology, University of California at San Francisco, 16100 Divisadero Street A634, San Francisco, CA 94143-1695, USA. katsutoshinohara@hotmail.com

The Urologic Clinics of North America
|December 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate Cancer.

European urology oncology·2026
Same author

Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate Cancer.

European urology focus·2025
Same author

The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern Era.

European urology oncology·2025
Same author

Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort.

European urology focus·2025
Same author

Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer.

The Journal of urology·2024
Same author

Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance.

European urology oncology·2024
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Prostate cancer incidence is rising due to increased screening. Cryotherapy is emerging as a promising alternative treatment for localized prostate cancer and for patients with biochemical progression after radiation therapy.

Area of Science:

  • Oncology
  • Urology

Background:

  • Prostate cancer incidence has more than doubled, with 220,900 new cases expected in 2003.
  • Increased use of prostate-specific antigen (PSA) screening, ultrasonography, and biopsies contribute to higher detection rates.
  • Treatment for prostate cancer, especially localized disease, remains controversial with no established consensus.

Purpose of the Study:

  • To explore cryotherapy as a viable alternative treatment for prostate cancer.
  • To evaluate cryosurgery's potential role for patients with biochemical progression after radiotherapy.
  • To assess the future role of cryosurgery in prostate cancer management.

Main Methods:

  • Review of technological developments in prostate cancer therapy.
  • Discussion of conventional treatments like radical prostatectomy, radiation therapy, and watchful waiting.

Related Experiment Videos

  • Exploration of cryotherapy as an alternative localized therapy.

    • Main Results:

    • Cryotherapy is gaining interest as an effective alternative with potentially limited morbidity.
    • Cryosurgery may be a suitable option for patients with localized tumors despite biochemical progression post-radiotherapy.
    • Technological advancements are enhancing the viability of cryotherapy.

    Conclusions:

    • Cryotherapy presents a promising alternative to conventional prostate cancer treatments.
    • It offers a potential solution for patients with recurrent or persistent localized disease.
    • Cryosurgery is expected to play a significant role in the future management of prostate cancer.